Evidence map›Paper›PMID 36873531›Full record

ArticleHeliyon2023

Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer.

Yucai Wu, Yangyang Xu, Shiming He, Yifan Li, Ninghan Feng, Jian Fan, Yanqing Gong, Xuesong Li, Liqun Zhou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yucai WuDepartment of Urology, Peking University First Hospital, Beijing, China.
Yangyang XuDepartment of Urology, Peking University First Hospital, Beijing, China.
Shiming HeDepartment of Urology, Peking University First Hospital, Beijing, China.
Yifan LiDepartment of Urology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Jiangsu, China.
Ninghan FengWuxi No 2 People's Hospital, Jiangsu, China.
Jian FanDepartment of Urology, Peking University First Hospital, Beijing, China.
Yanqing GongDepartment of Urology, Peking University First Hospital, Beijing, China.
Xuesong LiDepartment of Urology, Peking University First Hospital, Beijing, China.
Liqun ZhouDepartment of Urology, Peking University First Hospital, Beijing, China.
Peking University · CNWuxi No.2 People's Hospital · CNYangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Dysregulation of long noncoding RNAs (lncRNAs) has been reported to be associated with multiple tumors where they act as tumor suppressors or accelerators. The lncRNA Methods: Using cancer datasets from The Cancer Genome Atlas (TCGA) program, we analyzed the association between Results: The results indicated that Conclusions: These results suggest that

Indexed as

BCa, Bladder cancerBladder cancerCAFs, Cancer-associated fibroblastsCIBERSOFT, Cell-type Identification By Estimating Relative Subsets Of RNA TranscriptsCYTORCYTOR, Cytoskeleton regulator RNAEMT, Epithelial mesenchymal transformationImmune infiltrationImmunotherapyLncRNAs, Long non-coding RNAsMIBC, Muscle-invasive bladder cancerOS, Overall survivalPCA, Principal component analysisPD-1, Programmed cell death-1PD-L1, Programmed death ligand 1RT-qPCR, Reverse transcription-quantitative polymerase chain reactionSurvivalTCGA, The Cancer Genome AtlasTME, Tumor microenvironmentUMI, Unique molecular identifierUTUC, Upper-tract urothelial carcinoma

Identifiers

PMID36873531
PMCPMC9976329
OpenAlexW4320480636

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.